Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Riley Antony A
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Wagner Paul A.
Forte Biosciences | 8-K: Current report
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Kapoor Shivpreet Singh
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director VINCENT RICHARD G
Forte Biosciences | 3: Initial statement of beneficial ownership of securities-Director Kapoor Shivpreet Singh
Forte Biosciences | 3: Initial statement of beneficial ownership of securities-Director VINCENT RICHARD G
Forte Biosciences | 8-K: Current report
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director GRYSKA DAVID W
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Eichenfield Lawrence
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Kornfeld Steven
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Doberstein Stephen K
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director FINCK BARBARA K
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Brun Scott C.
Forte Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Williams Donald Allen
Forte Biosciences | 8-K: Current report
Forte Biosciences | 8-K: FORTE BIOSCIENCES, INC. ANNOUNCES SECOND QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE
Forte Biosciences | 10-Q: Q2 2024 Earnings Report
Forte Biosciences | DEF 14A: Definitive information statements
Forte Biosciences | ARS: Annual Report to Security Holders
No Data
No Data